120734
  • Log in
The Daily Sceptic
No Result
View All Result
  • Articles
  • About
  • Archive
    • ARCHIVE
    • NEWS ROUND-UPS
  • Forum
  • Donate
  • Newsletter
The Daily Sceptic
No Result
View All Result

Re-evaluation of Pfizer Trial Data Shows Zero Efficacy, Say Experts

by Will Jones
17 June 2022 3:24 PM
Study Claims Pfizer Vaccine is 95% Effective in Over 65s. But Should That Be 74%?

The expert group HART (Health Advisory and Recovery Team) has delved into the Pfizer trial documents released following a U.S. court order and discovered that according to Pfizer’s own antibody data the vaccine efficacy in the trial was massively overstated and appears to be as low as zero.

While the official results found only eight PCR-positive ‘cases’ in the vaccine arm, Pfizer’s antibody testing shows that in fact 75 people in the vaccinated arm seroconverted (developed N-type antibodies), implying there were actually 75 ‘cases’ of Covid in the vaccinated, not just eight.

By itself that would cut efficacy in half. However, HART points out that it’s been shown with the Moderna mRNA vaccine that only around 40% of the vaccinated who go on to have a symptomatic PCR-positive Covid ‘breakthrough’ infection develop N-type antibodies, owing to immune imprinting (‘original antigenic sin’) by the vaccine to favour S-type antibodies (which target the spike protein). Assuming this also applies to the Pfizer mRNA vaccine, this means the 75 seropositive individuals are only around 40% of the total number who had Covid, giving an estimated total of 188 Covid ‘cases’ in the vaccine arm – more than the 165 in the unvaccinated arm, implying zero vaccine efficacy or worse.

How did Pfizer get away with claiming there were only eight Covid cases in the vaccinated arm? Mainly by excluding PCR-positives in the jabbed until seven days after the second dose. The problem with this is that, since Covid waves tend to infect only 10-20% of a population, evidently not everyone is equally susceptible to the virus. This means if those most susceptible to the virus in the vaccine arm catch it in the weeks before they are ‘fully vaccinated’ and so don’t count towards the vaccine arm ‘cases’, those remaining in the vaccine arm of the trial will be primarily those who are less susceptible to the virus, and so the trial will suffer from survivor bias, exaggerating efficacy.

HART explains:

Pfizer set out in its protocol that efficacy would be measured based on PCR positive test results in symptomatic individuals and, as a secondary measure, N-antibody levels showing who had been infected. 

Pfizer chose to ignore PCR positive results, even in symptomatic people, if they occurred in the month before “seven days after the second dose”. However, the antibody testing is a measure of who had Covid for the entire period of the trial. Concerns about higher incidence in the early period after dosing, or an illusion of efficacy from a drug that caused cases to occur earlier rather than preventing cases, would be addressed by measuring the numbers who developed antibodies.

The original trial claimed there were only eight symptomatic PCR positive ‘cases’ in the dosed arm compared to 162 in the placebo arm. The graph always looked odd – how could the treatment arm have such a dramatic flattening to the horizontal?

There were 165 people who started with negative antibodies but became positive during the trial in the placebo arm. That is a pretty close match to the 165 who were positive by PCR testing. However, there were 75 in the vaccine arm, far more than the eight claimed by PCR testing. That would mean that treatment only reduced the risk of infection by about half the 95% claimed.

Only 40% of people who had been given Moderna produced N-antibodies after symptomatic, PCR positive infection. Moderna and Pfizer have products that are very similar in terms of mechanism of action, so it is not unreasonable to assume that a similar issue would be seen with Pfizer. 

If that is the case, then the 75 figure would only be a fraction of the people in the treatment arm who had been infected. Assuming the 40% figure holds, that would mean that there was no efficacy from Pfizer vaccination against risk of infection when measuring the entire period from first needle to end of the trial. 

Worth reading in full.

Tags: AntibodiesCasesHARTOriginal antigenic sinPCR TestPfizerVaccine efficacyVaccines

Donate

We depend on your donations to keep this site going. Please give what you can.

Donate Today

Comment on this Article

You’ll need to set up an account to comment if you don’t already have one. We ask for a minimum donation of £5 if you'd like to make a comment or post in our Forums.

Sign Up
Previous Post

Why the FDA Should Not Have Approved the Pfizer Covid Vaccine for Infants

Next Post

France Bans Gatherings “Due to Heatwave” as Germany Mulls Annual Mask Mandate – and China Uses Covid App to Target Protestors

Subscribe
Login
Notify of
Please log in to comment

Profanity and abuse will be removed and may lead to a permanent ban.

19 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

NEWSLETTER

To view today's newsletter click here

To receive our latest news in the form of a daily email, enter your details here:

DONATE

LISTED ARTICLES

  • Most Read
  • Most Commented
  • Editors Picks
Does the Oxford Study on Post-Vaccine Myocarditis Underestimate the Risk?

Serious Heart Inflammation 44 Times Higher After Covid Vaccination, Nature Study Finds

27 June 2022
by Will Jones
EU Renews Vaccine Passport Scheme Despite Overwhelmingly Negative Public Feedback

EU Renews Vaccine Passport Scheme Despite Overwhelmingly Negative Public Feedback

26 June 2022
by Will Jones
News Round-Up

News Round-Up

27 June 2022
by Will Jones
Climate Scientist Says Humans Cause Less Than 0.05°C of Global Warming and Warns of “Anarchy” From “Delusional” Net Zero Policies

Climate Scientist Says Humans Cause Less Than 0.05°C of Global Warming and Warns of “Anarchy” From “Delusional” Net Zero Policies

24 June 2022
by Chris Morrison
New Analysis: Covid’s Infection Fatality Rate Now Same as Seasonal Flu

New Analysis: Covid’s Infection Fatality Rate Now Same as Seasonal Flu

26 June 2022
by Toby Young
Student Awarded £60,000 of Taxpayers’ Money to Research Whether Puppets are Racist

Student Awarded £60,000 of Taxpayers’ Money to Research Whether Puppets are Racist

16
News Round-Up

News Round-Up

14
BBC Staff Told there are More than 150 Genders and Urged to Develop ‘Trans Brand’

BBC Staff Told there are More than 150 Genders and Urged to Develop ‘Trans Brand’

11
EU Renews Vaccine Passport Scheme Despite Overwhelmingly Negative Public Feedback

EU Renews Vaccine Passport Scheme Despite Overwhelmingly Negative Public Feedback

16
New Analysis: Covid’s Infection Fatality Rate Now Same as Seasonal Flu

New Analysis: Covid’s Infection Fatality Rate Now Same as Seasonal Flu

10
Does the Oxford Study on Post-Vaccine Myocarditis Underestimate the Risk?

Serious Heart Inflammation 44 Times Higher After Covid Vaccination, Nature Study Finds

27 June 2022
by Will Jones
Why Healthcare Settings Should Drop Their Mask Requirements

Masks are Not Protective, Says Health & Safety Executive

24 June 2022
by Niall McCrae
Daily Sceptic ‘Fact Checked’ Over Claim That CO2 Increase Lags Behind Global Warming So Cannot Cause It – But That is What the Data Show

Daily Sceptic ‘Fact Checked’ Over Claim That CO2 Increase Lags Behind Global Warming So Cannot Cause It – But That is What the Data Show

23 June 2022
by Chris Morrison
We Should Welcome the Lab Leak Theory, Argues Biologist

Did SARS-CoV-2 Originate in Wuhan in 2019 or Earlier Elsewhere?

23 June 2022
by John Collis
U.S. Medicines Regulator to Add Warning to Pfizer and Moderna Vaccines Over Link to Heart Inflammation

Covid Vaccines More Likely to Put You in Hospital Than Keep You Out, BMJ Editor’s Analysis of Pfizer and Moderna Trial Data Finds

22 June 2022
by Will Jones

SOCIAL LINKS

Free Speech Union
The Daily Sceptic
  • Home
  • About us
  • Donate
  • Privacy Policy

Facebook

Twitter

Instagram

RSS

Subscribe to our newsletter

© 2022 Skeptics Ltd.

No Result
View All Result
  • Articles
  • About
  • Archive
    • ARCHIVE
    • NEWS ROUND-UPS
  • Forum
  • Donate
  • Newsletter

© 2022 Daily Sceptic.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Please note: To be able to comment on our articles you'll need to be a registered donor

Already have an account?
Please click here to login Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
wpDiscuz
You are going to send email to

Move Comment